已收盤 05-08 16:00:00 美东时间
+0.670
+3.72%
BioCryst Pharma (NASDAQ:BCRX) released first-quarter financial results and host...
05-06 21:28
今日重点评级关注:Piper Sandler:维持Aclaris Therapeutics"超配"评级,目标价从7美元升至11美元;Evercore ISI集团:维持BioMarin Pharmaceutical"跑赢大市"评级,目标价从110美元升至120美元
05-06 11:29
Schindler selects Navan to modernize global travel program Navan selected by Schindler to modernize its global travel program, consolidating travel operations from a fragmented online booking model. Rollout to unify travel management across North America and Europe, initially covering Canada, US, Fr
05-05 16:00
U.S. RESEARCH ROUNDUP-Applied Materials, Axsome Therapeutics, Onsemi May 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Materials, Axsome Therapeutics and Onsemi on Tuesday. HIGHLIGHTS * Applied Materials AMAT
05-05 15:07
Navan data shows transatlantic business travel bookings rise 17.4% y/y Navan analysis showed Europe-U.S. transatlantic flight bookings rose 17.4% year over year. U.S.-UK business travel increased nearly 15% year over year. London remained top global hub for U.S. business travelers, followed by Toron
04-30 16:00
BNP Paribas analyst Navann Ty downgrades Organon (NYSE:OGN) from Outperform to Neutral and raises the price target from $12 to $14.
04-30 01:51
LOS ANGELES, April 22, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against ...
04-23 00:00
今日重点评级关注:HC Wainwright & Co.:维持Century Therapeutics"买入"评级,目标价从2美元升至5美元;Oppenheimer:维持Climb Bio"跑赢大市"评级,目标价从10美元升至18美元
04-22 12:41
今日重点评级关注:Ascendiant Capital:维持Knightscope"买入"评级,目标价从25美元升至26美元;杰富瑞:维持Allogene疗法"买入"评级,目标价从6美元升至10美元
04-16 10:14
Navan stock rises after Opella selects its AI platform for travel and expense management, targeting savings and efficiency gains.
04-15 19:53